What Is Hsil (Asc-H)

Cool What Is Hsil (Asc-H) 2022. Lsil was cin 1 (45.7%); For lroh and lsil, 31.1% and.

PPT Review of the Guidelines for Cervical Screening in New Zealand
PPT Review of the Guidelines for Cervical Screening in New Zealand from www.slideserve.com

Nur adlina binti alihad (2016299798) prepared by: Squamous includes squamous intraepithelial lesion (sil) category which encompasses a spectrum of squamous cell lesions. Hsil typically involves the tz of the cervix, which is derived from immature metaplasia.

Thus It May Be Difficult To Interpret When The Metaplasia.


A finding of abnormal cells in a pap test. It means there are abnormal squamous cells in the tissue that lines the outer part of the cervix. In this system, epithelial cell abnormality:

Hsil Typically Involves The Tz Of The Cervix, Which Is Derived From Immature Metaplasia.


For lroh and lsil, 31.1% and. Small atypical parakeratotic (sapk) cells with distinct and sharp angulated cell borders with tinge of cytoplasmic eosinophilia (arrowhead in b) (see also corresponding area in a) were. Hsil in immature squamous metaplasia.

The Cytological Features Associated With Clinical Outcome Of ‘Lsil Cannot Exclude Hsil (Lsil‐H)’ In Comparison With ‘Atypical Squamous Cells Cannot Exclude Hsil.


Lsil is usually due to a mild cellular change. Siti najihah binti mohamad salleh. Squamous includes squamous intraepithelial lesion (sil) category which encompasses a spectrum of squamous cell lesions.

Conventional Pap Smears Exhibiting Unequivocal Features Of 'Low Grade Squamous Intraepithelial Lesion' (Lsil) Are Occasionally Mixed With Some Cells Suspicious For, But Not.


Lroh was cin 1 (46.7%) and hsil was cin 2/3 (64.4%). Lsil was cin 1 (45.7%); Nur adlina binti alihad (2016299798) prepared by:

The Most Common Histologic Outcome For Asc‐H Was Cin2/3 (32.6%);


Hsil (encompassing moderate and severe dysplasia/ cis/cin 2 and cin 3) with features suspicious for invasion (if suspected) squamous cell carcinoma.

Posting Komentar untuk "What Is Hsil (Asc-H)"